TWD
MED icon

True Wealth Design’s Medifast MED Stock Holding History

True Wealth Design’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-90
Closed -$955 – 2709
2026
Q2 		$955 Buy
90
+43
+91% +$496 ﹤0.01% 1993
2026
Q1 		$479 Buy
47
+17
+57% +$183 ﹤0.01% 2072
2025
Q4 		$321 Sell
30
-130
-81% -$1.56K ﹤0.01% 2098
2025
Q3 		$2.19K Buy
160
+111
+227% +$1.55K ﹤0.01% 1421
2025
Q2 		$689 Buy
49
+9
+23% +$118 ﹤0.01% 1610
2025
Q1 		$540 Sell
40
-75
-65% -$1.13K ﹤0.01% 1516
2024
Q4 		$2.03K Sell
115
-168
-59% -$3.12K ﹤0.01% 732
2024
Q3 		$5.42K Buy
+283
New +$5.45K ﹤0.01% 535

Other funds holding MED

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MAFA
MJT & Associates Financial Advisory Monteviceo, Minnesota $155M AUM 15.7% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

True Wealth Design's MED Position: Q3 2026 in Review

True Wealth Design sold out of Medifast (MED) in Q3 2026, closing a stake of 90 shares — an estimated $955 sold.

True Wealth Design first reported a position in MED in Q3 2024 and held it in 8 quarters. The position peaked at $5.42K in Q3 2024. 4 funds tracked by Wall St. Rank hold MED as of Q3 2026.

  • True Wealth Design reported no remaining Medifast position as of Q3 2026 after selling out during the quarter.
  • True Wealth Design sold 90 Medifast shares in Q3 2026, an estimated $955.
  • True Wealth Design first reported a position in Medifast in Q3 2024 and held it in 8 quarters.
  • True Wealth Design's Medifast position peaked at $5.42K in Q3 2024.
  • 4 funds tracked by Wall St. Rank held Medifast as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.